www.bioscience.co.uk
Sales & Support: +44 (0)1223 316 855

*

Anti-PCSK9 (Alirocumab), Human IgG1 Antibody

Supplier:
Catalogue number:
A2153-100
Size:
100 µg
Product is available in:
  • UK
  • Ireland
  • Europe
  • USA
  • Rest of World
£581.00 Estimated delivery Wed 23 Jun
Shipping is calculated in checkout

The research-grade biosimilar antibody is a fully human IgG1 monoclonal antibody that binds to and inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9), an enzyme that has "gain-of-function" mutations in autosomal dominant hypercholesterolemia. PCSK9 is secreted by the liver and binds to the LDL receptors in serum and marks them for lysosomal degradation. As a result, the LDL receptors are unable to recycle to the plasma membrane, thus reducing their binding to LDL-C and subsequent clearance of LDL-C from plasma. Therefore, by binding to free PCSK9, the biosimilar allows more LDL-C reuptake by the liver and facilitates a higher rate of clearance of LDL-C. The original drug received approval from the FDA as a second-line of treatment for heterozygous familial hypercholesterolemia in adults, whose LDL-C was not controlled by the combination of diet and statin treatment.

Product Type:

Antibodies

Species Reactivity:

Human

Storage Temp:

-80°C

Antibody Host:

Recombinant

Antibody Isotype:

IgG1, kappa

Formulation:

In PBS, pH 7.5

Antibody Type:

Monoclonal

UNSPSC Code:

12352203

Details Cat number & supplier Size Price
Anti-PD-L1 (Avelumab), Human IgG1 Antibody A2152-100 · BioVision
A2152-100
BioVision
100 µg £581.00
100 µg
view
Anti-IL-17α (Secukinumab), Human IgG1 Antibody A2154-100 · BioVision
A2154-100
BioVision
100 µg £581.00
100 µg
view
Anti-CD38 (Daratumumab), Human IgG1 Antibody A2151-100 · BioVision
A2151-100
BioVision
100 µg £581.00
100 µg
view
Anti-IL-17Rα (Brodalumab), Human IgG2 Antibody A2155-100 · BioVision
A2155-100
BioVision
100 µg £581.00
100 µg
view
Anti-TNFSF11 (Denosumab), Human IgG2 Antibody A2150-100 · BioVision
A2150-100
BioVision
100 µg £581.00
100 µg
view
Anti-PD-1 (Sintilimab), Human IgG4 Antibody A2156-100 · BioVision
A2156-100
BioVision
100 µg £581.00
100 µg
view
Anti-IL-17α (Ixekizumab), Humanized Antibody A2149-100 · BioVision
A2149-100
BioVision
100 µg £581.00
100 µg
view